Effectiveness and safety of Wuling capsule for post stroke depression: A systematic review

Complementary Therapies in Medicine

Volumn 22, Issue 3, 2014, Pages 549-566

  Peng, Le ^a   Zhang, Xin ^a   Kang, De ying ^a   Liu, Xue ting ^a   Hong, Qi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Conventional treatment; Meta analysis; Post stroke depression (PSD); Systematic review; Wuling capsule

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DEANXIT; FLUOXETINE; PAROXETINE; SERTRALINE; UNCLASSIFIED DRUG; WULING; HERBACEOUS AGENT;

ANOREXIA; BLURRED VISION; COMPARATIVE EFFECTIVENESS; CONSTIPATION; DEPRESSION; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FLATULENCE; HAMILTON SCALE; HAND TREMOR; HEADACHE; HUMAN; INSOMNIA; META ANALYSIS; NAUSEA AND VOMITING; ORTHOSTATIC HYPOTENSION; POST STROKE DEPRESSION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT DURATION; WEIGHT GAIN; XEROSTOMIA; ADULT; CEREBROVASCULAR ACCIDENT; FEMALE; MALE;

ADULT; DEPRESSION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; STROKE;

EID: 84901927523     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.04.005     Document Type: Review

References (53)

1. Pan J.H., Song X.Y., Lee S.Y., Kwok T. Longitudinal analysis of quality of life for stroke survivors using latent curve models. Stroke 2008, 39:2795-2802.
2. Lo R.S., Cheng J.O., Wong E.M., Tang W.K., Wong L.K., Woo J., et al. Handicap and its determinants of change in stroke survivors one-year follow-up study. Stroke 2008, 39:148-153.
3. Arseniou S., Arvaniti A., Samakouri M. Post-stroke depression: recognition and treatment interventions. PsyCHNatrike 2011, 22:240-248.
4. Zhang G.C., Fu W.B., Xu N.G., Liu J.H., Zhu X.P., Liang Z.H., et al. Meta-analysis of the curative effect of acupuncture on post-stroke depression. J Tradit CHNn Med 2012, 32:6-11.
5. Huang B.Y., Liao Z.A., Fang M.H. The clinical research overview of post stroke depression. CHNn J Phys Med Rehabil 2005, 27:315-317.
6. Carod-Artal F.J. Post-stroke depression (II): its differential diagnosis, complications and treatment. Rev Neurol 2006, 42:238-244.
7. Paolucci S. Epidemiology and treatment of post stroke depression. NeruopsyCHNatr Dis Treat 2008, 4:145-154.
8. Bartoli F., Lillia N., Lax A., Crocamo C., Mantero V., Carrà G., et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat 2013.
9. Hackett M.L., Anderson C.S., House A., Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008, 4.
10. Emsr E. St. John's Wort, an antidepressant? A systematic, criteria-based review. Phytomedicine 1995, 2:67-71.
11. Butler L., Pilkington K. CHNnese herbal medicine and depression: the research evidence. Evid Based Complement Alternat Med 2013.
12. Xu C., Luo L., Tan R.X. Antidepressant effect of three traditional CHNnese medicines in the learned helplessness model. J Ethnopharmacol 2004, 91:345-349.
13. Almeida R.N., Navarro D.S., de Assis T.S., de Medeiros I.A., Thomas G. Antidepressant effect of an ethanolic extract of the leaves of Cissampelos sympodialis in rats and mice. J Ethnopharmacol 1998, 63:247-252.
14. Luo L., Wang J.N., Kong L.D., Jiang Q.G., Tan R.X. Antidepressant effects of Banxia Houpu decoction, a traditional CHNnese medicinal empirical formula. J Ethnopharmacol 2000, 73:277-281.
15. Li Z., Zhao Z.X. Application of Wuling capsule in the Basic and Clinical Research. CHNn Trad Patent Med 2010, 32:120-121.
16. Liao M.L., Yu J. Wuling capsule. J CHNn New Drugs 2000, 9:797.
17. Wu D., Xie Z.X., Di P. Clinical application and efficacy of Wuling capsule. J CHNna Prescript Drug 2012, 10:43-45.
18. Neurology Branch of CHNnese Medical Association Key points for diagnosing cerebrovascular diseases. CHNn J Neurol 1996, 29:379-380.
19. Turner-Stokes L., Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact. Clin Rehabil 2002, 16:231-247.
20. World Health Organization The ninth revision of the International Classification of Diseases and Related Health Problems (ICD-9) 1978, Geneva, Switzerland. 9th ed.
21. World Health Organization The tenth revision of the International Classification of Diseases and Related Health Problems (ICD-10) 1992, Geneva, Switzerland. 10th ed.
22. PsyCHNatry Branch of CHNnese Medical Association Category and diagnostic criteria of mental disorder of CHNna 2001, Shandong Science and Technology Press, Ji'nan, CHNna. 3rd ed.
23. American PsyCHNatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III) 1980, Washington, America. 3rd ed.
24. American PsyCHNatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) 1987, Washington, America. 3rd ed.
25. American PsyCHNatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, Washington, America. 4th ed.
26. American PsyCHNatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-V) 2013, Arlington, America. 5th ed.
27. Higgins J.P.T., Sally G. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011) 2011, The Cochrane Collaboration, Available from
28. Norman G.R. Issues in the use of change scores in randomized trials. J Clin Epidemiol 1989, 42:1097-1105.
29. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997, 315:629-634.
30. Chen Y., Gao L., He W.Y. Curative effect analysis of Wuling capsule for post stroke depression. CHNn Trad Patent Med 2009, 31:503-504.
31. Hu C.M., Guo S.S. Clinical analysis of Wuling capsule for 60 cases of post stroke depression. CHNn Trad Patent Med 2008, 30(Suppl.):12-13.
32. Meng L. Clinical observation of Wuling capsule for post stroke depression CHNnese. J Pract Nervous Dis 2011, 14:72-73.
33. Fu J.L., Zhao Y.W., Sun X.J. Efficacy and safety of Deanxit combined with Wuling capsule in treating post-stroke depression: a randomized controlled trial. J CHNn Integr Med 2008, 6:258-261.
34. Ran S.L., Yan K., Lin T., Huang M.C. Clinical study of Wuling capsule for post stroke depression. CHNn Trad Patent Med 2010, 32:1271-1272.
35. Zhang L.L., Mei J.S., Zhang S.L. Therapeutic effect observation of Wuling capsule combined with Deanxit for post stroke depression. Contemp Med 2010, 16:115-116.
36. Wu Y.H., Wang S.L., Jiang X.Q. Deanxit combined with Wuling capsule for post stroke depression. Guangming J CHNn Med 2013, 28:104-105.
37. Liu J.X. Effect on the depression and cognition of patients with stroke treated by Wuling capsule. Mod Prevent Med 2009, 36:378-379. 384.
38. Liu W.H. Application of Wuling capsule for post stroke depression. Health Must-read Mag 2011, 10:317.
39. Xu B., Zhou W.Y., Zhang S.J. Observation on effect of Wuling capsule in treating post stroke depression. CHNn J Integr Trad West Med 2007, 27:640-642.
40. Shi Q., Liu X.Y., Chen Y.J., Yu J. Observation on curative effect of Wuling capsule combined with Fluoxetine for post stroke depression and neurologic deficit. CHNn Trad Patent Med 2008, 30:804-806.
41. Wan A.L., Yuan Y.F. Curative effects on post stroke depression with Wuling capsule versus Sailuote. CHNn J Clin Rehabil 2006, 10:4-6.
42. Xiang L., Li S.J., Hu Y.M. Observation on the effects of Wuling capsule combined with paroxetine for post-stroke depression. CHNn J Pract Nervous Dis 2011, 14:36-38.
43. Hu J., Yuan L.L. Wuling capsule union Sertraline treatment of 45 patients with post-stroke depression clinical observation. Med J CHNn People's Health 2009, 21:1882-1883.
44. Wang Y.Q., Song S.J., Jiang X. Clinical research of Wuling capsule combined with Zoloft for post stroke depression. Zhejiang J Trad CHNn Med 2007, 42:202-203.
45. Ran S.L., Yan K., Lin T., Qiao H. Clinical research of Citalopram combined with Wuling capsule on the treatment of post-stroke depression. J Qiqihar Univ Med 2012, 33:1885-1887.
46. Ma Z.Z., Zuo P.P., Chen W.R., Tang L.J., Shen Q., Sun X.H., et al. Studies on the sedative and sleeping effects of Wuling mycelia and its pharmacological mechanism. CHNn Pharm J 1999, 34:374-377.
47. Sapolsky R. Biology and human behavior: the neurological origins of individuality 2005, 19-20. The TeaCHNng Company. 2nd ed.
48. Sichuan Institute of traditional CHNnese Medicine Sichuan traditional CHNnese medicine records 1979, vol. 2:1434. Sichuan People's Press, Chengdu.
49. Qing'e T. Neurobiological mechanisms of depression and research of antidepressants. CHNna Pharm 2005, 1623:1828-1830.
50. Li S.M., Lin Y.B., Tan S.H. Effectiveness analysis of a combination of Deanxit and Wuling capsule for post stroke depression. CHNna Pract Med 2010, 5:149-150.
51. Calabrese E.J., Baldwin L.A. Defining hormesis. Hum Exp Toxicol 2002, 21:91-97.
52. Liu J., Manheimer E., Shi Y., Gluud C. CHNnese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis. J Altern Complement Med 2004, 10:1041-1051.
53. CONSORT 2010 checklist of information to include when reporting randomised trial. Available from: http://www.consort-statement.org/.